Location History:
- Philadelphia, PA (US) (2012)
- Bryn Mawr, PA (US) (2020)
Company Filing History:
2 out of 243 
1 out of 2 
1 out of 1,437 
Years Active: 2012-2020
Title: Kiranmai Gumireddy: Innovator in Lung Cancer Diagnosis and MicroRNA Modulation
Introduction
Kiranmai Gumireddy is a notable inventor based in Bryn Mawr, Pennsylvania. He has made significant contributions to the field of medical diagnostics, particularly in lung cancer detection and microRNA modulation. With two patents to his name, Gumireddy's work is paving the way for advancements in cancer screening and treatment.
Latest Patents
Gumireddy's latest patents include a method and systems for lung cancer diagnosis. This invention focuses on high-risk screening, diagnosis, prognosis, and surveillance of lung cancer. The method involves obtaining the expression level of the AKAP4 gene from a population of cells in the blood of a test subject. By comparing this expression level with a predetermined reference value, a diagnosis or evaluation of lung cancer can be made.
Another significant patent is related to microRNA modulators and methods for identifying and using them. This invention provides a method for identifying agents that modulate microRNA activity. It involves contacting a cell with a microRNA and a microRNA binding sequence linked to a nucleic acid molecule encoding a reporter protein. The test agent's effect on the expression of the reporter protein helps identify microRNA modulators, which can be used to inhibit microRNA activity and potentially treat diseases.
Career Highlights
Throughout his career, Kiranmai Gumireddy has worked with reputable organizations such as Valley Health System and The Wistar Institute of Anatomy & Biology. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Gumireddy has collaborated with notable colleagues, including Qihong Huang and Louise C Showe. Their combined efforts in research have furthered the understanding of cancer diagnostics and treatment methodologies.
Conclusion
Kiranmai Gumireddy's innovative work in lung cancer diagnosis and microRNA modulation highlights his significant contributions to medical science. His patents reflect a commitment to improving healthcare outcomes through advanced diagnostic methods.